Jw Life Science Corp Cash Flow Quality Index
Jw Life Science Corp cash flow quality index. Jw Life Science Corp (234080) has a Cash Flow Quality Index of 2.18x as of June 2026. Operating cash flow of ₩17.43 Billion exceeds net income of ₩8.01 Billion, indicating high earnings quality where cash backs reported profits. Explore 234080 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jw Life Science Corp (2015–2025)
Cash flow quality index of Jw Life Science Corp from 2015 to 2025. Historical Cash Flow Quality Index for Jw Life Science Corp across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Jw Life Science Corp (234080) balance sheet quality index to measure how much of total assets are equity-financed.
Jw Life Science Corp Cash Flow Quality Index by Year (2015–2025)
Jw Life Science Corp cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for Jw Life Science Corp. For the full cash flow conversion analysis, see cash efficiency ratio of Jw Life Science Corp.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.42x | ₩40.54 Billion | ₩28.61 Billion | ▲ +23.0% |
| 2024 | 1.15x | ₩50.69 Billion | ₩43.99 Billion | ▼ -13.7% |
| 2023 | 1.34x | ₩37.57 Billion | ₩28.14 Billion | ▲ +41.4% |
| 2022 | 0.94x | ₩14.13 Billion | ₩14.96 Billion | ▼ -59.6% |
| 2021 | 2.34x | ₩30.17 Billion | ₩12.91 Billion | ▲ +44.6% |
| 2020 | 1.62x | ₩46.75 Billion | ₩28.94 Billion | ▲ +48.8% |
| 2019 | 1.09x | ₩24.28 Billion | ₩22.35 Billion | ▼ -52.4% |
| 2018 | 2.28x | ₩36.13 Billion | ₩15.82 Billion | ▲ +73.8% |
| 2017 | 1.31x | ₩22.05 Billion | ₩16.78 Billion | ▲ +23.9% |
| 2016 | 1.06x | ₩16.08 Billion | ₩15.16 Billion | ▼ -47.3% |
| 2015 | 2.01x | ₩25.90 Billion | ₩12.86 Billion | — |